Clinical significance for detection of AFP mRNA in peripheral blood in patients with hepatocellular carcinoma

Yang Liu,Baihe Zhang,Guangxiang Qian,Han Chen,Mengchao Wu,Jiliang Fu,Changhui Huang
DOI: https://doi.org/10.13329/j.cnki.zyyjk.2010.10.050
1999-01-01
Abstract:[Objective]To study the expression of AFP (alpha-fetoprotein)-mRNA in the peripheral blood of patients with and hepatocellular carcinoma (HCC) and its clinical significance.[Methods]The expression of AFP-mRNA in the peripheral blood of 25 patients with HCC was tested by fluorescent quantitative RT-PCR.[Results]The expression rate of AFP-mRNA in the peripheral blood of HCC patients was significantly higher than that of patients with hepatitis and liver cirrhosis (P<0.01).The expression of AFP-mRNA in the peripheral blood of HCC patients was related to extrahepatic metastasis (P<0.05),and it was not related to clinical stage,serum AFP level,diameter and number of tumor (P>0.05).The positive rate of AFP-mRNA in the peripheral blood of HCC patients of the first week after operation was significantly lower than that before operation (P<0.05).[Conclusion]AFP-mRNA can be used as the marker of hepatoma cells in blood circulation.The monitoring of AFP-mRNA before and after operation is helpful to predict the risk of tumor recurrence,and it can be used to guide the anti-tumor therapy.
What problem does this paper attempt to address?